subject: CHEBI:4875

subject_name: Etanercept

object_name: rheumatoid arthritis

upstream_resource_ids: infores:dailymed infores:faers


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: plasma cell myeloma


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: dyspepsia


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: multiple sclerosis


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: atopic eczema


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA


subject: CHEBI:31174

subject_name: Adapalene

object_name: acne


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:135983

subject_name: Teriparatide

object_name: osteoporosis


subject: CHEBI:50122

subject_name: Rosiglitazone

object_name: diabetes mellitus


subject: CHEBI:78540

subject_name: Apremilast

object_name: psoriasis


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:4875

object_name: psoriatic arthritis


subject: CHEBI:4875


subject: UNII:884KT10YB7

object_name: Heartburn


subject: UNII:7D0YB67S97

subject_name: Abatacept


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Crohn disease


subject: UNII:DLG4EML025

subject_name: Secukinumab


subject: CHEBI:63115

subject_name: Fingolimod


subject: UNII:420K487FSG

object_name: asthma


subject: CHEBI:3766

subject_name: Clozapine

object_name: schizophrenia


subject: CHEBI:5931

subject_name: insulin human

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: chronic obstructive pulmonary disease


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:76612

subject_name: Ibrutinib

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: rheumatoid arthritis


subject: UNII:U782C039QP

subject_name: GLATIRAMER


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: ulcerative colitis


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab


subject: CHEBI:70752

subject_name: Dabigatran

object_name: atrial fibrillation


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:68540

subject_name: Teriflunomide

object_name: multiple sclerosis


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:2P471X1Z11

subject_name: Omalizumab


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: CHEBI:78540

subject_name: Apremilast


subject: UNII:9RV78Q2002


subject: UNII:DLG4EML025

subject_name: Secukinumab


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:34385

subject_name: Dalfampridine


subject: CHEBI:4875

subject_name: Etanercept

object_name: ankylosing spondylitis


subject: CHEBI:45783

subject_name: Imatinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:4EQZ6YO2HI

object_name: postmenopausal osteoporosis

knowledge_level: observation


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: acne


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: psoriasis


subject: UNII:WTT295HSY5

subject_name: Dulaglutide


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: CHEBI:50275

subject_name: Esomeprazole


subject: UNII:B72HH48FLU


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: myelofibrosis


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: leukopenia


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Hypercholesterolemia


subject: UNII:FU77B4U5Z0

object_name: Crohn disease


subject: UNII:91X1KLU43E

subject_name: Golimumab


subject: CHEBI:5931

subject_name: insulin human

object_name: diabetes mellitus


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: pulmonary hypertension


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:2668

subject_name: Amlodipine

object_name: hypertension


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: asthma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: plasma cell myeloma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Myelodysplasia


subject: CHEBI:6801


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: Parkinson disease


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: secondary hyperparathyroidism


subject: CHEBI:52172

subject_name: Nilotinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:54K37P50KH

subject_name: Valbenazine

object_name: tardive dyskinesia


subject: PUBCHEM.COMPOUND:118984450


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: migraine


subject: CHEBI:6437

subject_name: Levetiracetam

object_name: epilepsy


subject: CHEBI:187893

subject_name: Baclofen

object_name: Spasticity


subject: CHEBI:9123

subject_name: Sertraline

object_name: Depressed mood


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: hypothyroidism


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: HIV infection


subject: CHEBI:2549

subject_name: Albuterol


subject: CHEBI:70839

subject_name: Dasatinib


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: EXCESS LMW-DNA


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: psoriasis


subject: CHEBI:36795

subject_name: Duloxetine


subject: CHEBI:5938

subject_name: Interferon beta-1b

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:118984450

object_name: type 2 diabetes mellitus


subject: CHEBI:7936

subject_name: Paroxetine


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: Crohn disease


subject: CHEBI:64356

subject_name: Pregabalin

object_name: fibromyalgia


subject: CHEBI:71193

subject_name: Liraglutide


subject: CHEBI:9943

subject_name: Venlafaxine


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: relapsing-remitting multiple sclerosis


subject: UNII:A10SJL62JY


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: hypertension


subject: CHEBI:194186

subject_name: Tirzepatide


subject: UNII:3ZO554A4Q8

subject_name: Voxelotor

object_name: sickle cell disease


subject: UNII:53AXN4NNHX

subject_name: semaglutide


subject: CHEBI:9927

subject_name: Valsartan


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: eosinophilic esophagitis


subject: CHEBI:90942

subject_name: Ixazomib

object_name: plasma cell myeloma


subject: CHEBI:6942

subject_name: Minoxidil

object_name: alopecia


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:114785

subject_name: Erlotinib

object_name: lung cancer


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:9139

subject_name: Sildenafil

object_name: impotence


subject: CHEBI:3219

subject_name: Bupropion

object_name: Depressed mood


subject: CHEBI:133021

subject_name: Venetoclax

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: dry eye syndrome


subject: CHEBI:7465

subject_name: Naltrexone

object_name: alcohol abuse


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: acquired polycythemia vera


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: epilepsy


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: rheumatoid arthritis


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: psoriasis


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: migraine


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: Abdominal pain


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: multiple sclerosis


subject: CHEBI:10650

subject_name: Sumatriptan


subject: CHEBI:82720

subject_name: Empagliflozin

object_name: type 2 diabetes mellitus


subject: CHEBI:30742

subject_name: macrogol

object_name: Constipation


subject: CHEBI:64356

subject_name: Pregabalin

object_name: neuralgia


subject: UNII:I8309403R0

subject_name: Peginterferon beta-1a


subject: CHEBI:8871

subject_name: Risperidone

object_name: schizophrenia


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: ankylosing spondylitis


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:50730

subject_name: Montelukast

object_name: asthma


subject: UNII:B6E7K36KT8

subject_name: Cenegermin

object_name: neurotrophic keratopathy


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: hemolytic-uremic syndrome


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:176844

subject_name: Niraparib

object_name: ovarian cancer


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: bipolar disorder


subject: CHEBI:60799

subject_name: Esketamine

object_name: Depressed mood


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: diffuse large B-cell lymphoma


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:65347

subject_name: Carfilzomib

object_name: plasma cell myeloma


subject: UNII:71492GE1FX

subject_name: Benralizumab


subject: CHEBI:63115

subject_name: Fingolimod

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:71940

subject_name: Tadalafil

object_name: impotence


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: psoriasis


subject: CHEBI:40237

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:118984450

object_name: type 1 diabetes mellitus 1


subject: CHEBI:30742

subject_name: macrogol

object_name: digestive system disorder


subject: CHEBI:64356

subject_name: Pregabalin

object_name: peripheral nervous system disorder


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: psoriatic arthritis


subject: CHEBI:36791

subject_name: Escitalopram


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer

object_name: Hyperkalemia


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: hyperlipidemia


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: pulmonary embolism


subject: CHEBI:5118

subject_name: Fluoxetine


subject: UNII:31YO63LBSN

subject_name: Nivolumab

object_name: melanoma


subject: CHEBI:47381

subject_name: Diclofenac

object_name: arthritis


subject: CHEBI:50861

subject_name: Treprostinil

object_name: pulmonary hypertension


subject: CHEBI:83804

subject_name: Paliperidone

object_name: schizophrenia


subject: CHEBI:3723

subject_name: Citalopram

object_name: Depressed mood


subject: CHEBI:8774

subject_name: Ramipril

object_name: hypertension


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Heartburn


subject: CHEBI:83353

subject_name: Agalsidase beta

object_name: Fabry disease


subject: CHEBI:6402

subject_name: Leflunomide

object_name: rheumatoid arthritis


subject: UNII:31YO63LBSN

object_name: non-small cell lung carcinoma


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: plasma cell myeloma


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:45783

subject_name: Imatinib

object_name: Plexosarcoma


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: idiopathic urticaria


subject: CHEBI:74947

subject_name: Thalidomide


subject: UNII:AVK0I6HY2U

subject_name: Abaloparatide

object_name: postmenopausal osteoporosis


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: dermatitis


subject: CHEBI:72296

subject_name: Apixaban

object_name: atrial fibrillation


subject: CHEBI:7735

subject_name: Olanzapine


subject: CHEBI:161680

subject_name: Aztreonam

object_name: cystic fibrosis


subject: CHEBI:31932

subject_name: olmesartan


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: type 2 diabetes mellitus


subject: CHEBI:41423

subject_name: Celecoxib

object_name: arthritis


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: bipolar disorder


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: ankylosing spondylitis


subject: CHEBI:7798

subject_name: Oseltamivir

object_name: influenza


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: diabetes mellitus


subject: UNII:2P471X1Z11

object_name: chronic idiopathic urticaria


subject: UNII:AVK0I6HY2U

object_name: osteoporosis


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: Depressed mood


subject: CHEBI:4875

subject_name: Etanercept

object_name: juvenile idiopathic arthritis


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: urinary tract infection


subject: CHEBI:6538

subject_name: Loratadine

object_name: Allergy


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: hypopituitarism


subject: CHEBI:69478

subject_name: Cannabidiol

object_name: Lennox-Gastaut syndrome


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: hemophilia A


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Angina pectoris


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: familial hypercholesterolemia


subject: CHEBI:10125

subject_name: Zolpidem

object_name: insomnia


subject: CHEBI:6427

subject_name: Leuprolide

object_name: endometriosis


subject: CHEBI:63925

subject_name: PhXa 85

object_name: glaucoma


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:5931

subject_name: insulin human

object_name: type 1 diabetes mellitus 1


subject: CHEBI:53760

subject_name: Eszopiclone


subject: CHEBI:134689

subject_name: Rucaparib

object_name: ovarian cancer


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:135957

subject_name: Voclosporin

object_name: lupus nephritis


subject: CHEBI:82698

subject_name: Suvorexant


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: Alzheimer disease


subject: CHEBI:9123

subject_name: Sertraline

object_name: anxiety


subject: CHEBI:42797

subject_name: Gabapentin

object_name: neuralgia


subject: CHEBI:2038

subject_name: Azacitidine

object_name: Myelodysplasia


subject: UNII:5Z9SP3X666

subject_name: Nusinersen

object_name: spinal muscular atrophy


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: non-Hodgkin lymphoma


subject: CHEBI:2549

subject_name: Albuterol

object_name: chronic obstructive pulmonary disease


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: diffuse large B-cell lymphoma


subject: CHEBI:145994

subject_name: Remdesivir


subject: CHEBI:90943

subject_name: Osimertinib

object_name: non-small cell lung carcinoma


subject: CHEBI:6775

subject_name: Mesalazine

object_name: ulcerative colitis


subject: CHEBI:68551

subject_name: Linaclotide

object_name: Constipation


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: gastric ulcer


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: liver carcinoma


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: West syndrome


subject: UNII:6T8C155666

subject_name: Ipilimumab

object_name: melanoma


subject: CHEBI:2663

subject_name: Amiodarone

object_name: atrial fibrillation


subject: CHEBI:71200

subject_name: Tofacitinib


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: ankylosing spondylitis


subject: CHEBI:48538

subject_name: Apomorphine

object_name: Parkinson disease


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: primary progressive multiple sclerosis


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: psoriatic arthritis


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: atypical hemolytic-uremic syndrome


subject: CHEBI:230846

subject_name: Pegvaliase

object_name: phenylketonuria


subject: CHEBI:66903

subject_name: Vismodegib

object_name: basal cell carcinoma


subject: UNII:A3ULP0F556

object_name: myasthenia gravis


subject: CHEBI:83766

subject_name: Olaparib

object_name: ovarian cancer


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: epilepsy


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Heartburn


subject: CHEBI:114785

subject_name: Erlotinib

object_name: non-small cell lung carcinoma


subject: CHEBI:567361

subject_name: Cladribine

object_name: multiple sclerosis


subject: CHEBI:64356

subject_name: Pregabalin

object_name: diabetic neuropathy


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: atopic eczema


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: migraine


subject: CHEBI:76612

subject_name: Ibrutinib

object_name: mantle cell lymphoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: plasma cell myeloma


subject: CHEBI:9139

subject_name: Sildenafil

object_name: pulmonary hypertension


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:50924

subject_name: Sorafenib

object_name: liver carcinoma


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:45409

subject_name: Ritonavir

object_name: HIV infection


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: diabetes mellitus


subject: CHEBI:2611

subject_name: Alprazolam

object_name: anxiety


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Depressed mood


subject: CHEBI:85994

object_name: endometrial cancer


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: psoriasis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: non-small cell lung carcinoma


subject: CHEBI:9434

subject_name: Telmisartan

object_name: hypertension


subject: CHEBI:78543

subject_name: Ponatinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: inflammatory bowel disease


subject: CHEBI:6541

subject_name: Losartan


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: urticaria


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: dry eye syndrome


subject: CHEBI:2453

subject_name: Acyclovir

object_name: herpes zoster


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:8871

subject_name: Risperidone

object_name: bipolar disorder


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Hypercholesterolemia


subject: CHEBI:31524

subject_name: Droxidopa

object_name: orthostatic hypotension


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:28864

subject_name: Tobramycin

object_name: cystic fibrosis


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: ulcerative colitis


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: psoriatic arthritis


subject: CHEBI:135351

subject_name: Rotigotine

object_name: Parkinson disease


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: primary biliary cholangitis


subject: CHEBI:50122

subject_name: Rosiglitazone

object_name: type 2 diabetes mellitus


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: narcolepsy


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Arthralgia


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: acute coronary syndrome


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Depressed mood


subject: UNII:91X1KLU43E

subject_name: Golimumab


subject: CHEBI:59560

subject_name: Sapropterin

object_name: phenylketonuria


subject: CHEBI:135939

subject_name: Lacosamide

object_name: epilepsy


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: multiple sclerosis


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Headache


subject: UNII:Q6U6J48BWY

subject_name: Imiglucerase

object_name: Gaucher disease


subject: CHEBI:15765

subject_name: Levodopa


subject: CHEBI:6532

subject_name: Loperamide

object_name: diarrhea


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:76607

subject_name: Macitentan

object_name: pulmonary hypertension


subject: CHEBI:134726

subject_name: Istradefylline


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: Hallucinations


subject: CHEBI:66901

subject_name: Ivacaftor

object_name: cystic fibrosis


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: osteoporosis


subject: CHEBI:229599

subject_name: Trofinetide

object_name: Rett syndrome


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: age-related macular degeneration


subject: UNII:ZL1R02VT79

object_name: macular degeneration


subject: CHEBI:90943

subject_name: Osimertinib

object_name: lung cancer


subject: CHEBI:31355

subject_name: Carboplatin

object_name: ovarian cancer


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: benign prostatic hyperplasia


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Allergy


subject: CHEBI:5134

subject_name: Fluticasone

object_name: asthma


subject: UNII:Z80293URPV

subject_name: Ozanimod


subject: CHEBI:65349

subject_name: Mirabegron

object_name: Urinary Urgency


subject: CHEBI:63616

subject_name: Pemetrexed

object_name: non-small cell lung carcinoma


subject: UNII:DTI67O9503

subject_name: Alglucosidase alfa

object_name: glycogen storage disease II


subject: CHEBI:42797

subject_name: Gabapentin

object_name: peripheral nervous system disorder


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: psoriasis


subject: CHEBI:5938

subject_name: Interferon beta-1b

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:7726

subject_name: octreotide

object_name: acromegaly


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: psoriatic arthritis


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: Crohn disease


subject: CHEBI:63631

subject_name: Topiramate

object_name: migraine


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: diabetes mellitus


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: hypertension


subject: CHEBI:5062

subject_name: Finasteride

object_name: alopecia


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:72296

subject_name: Apixaban

object_name: pulmonary embolism


subject: CHEBI:5959

subject_name: Irbesartan


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Menorrhagia


subject: CHEBI:7735

subject_name: Olanzapine

object_name: bipolar disorder


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Hypercholesterolemia


subject: UNII:420K487FSG

subject_name: Dupilumab


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Allergy


subject: CHEBI:2904

subject_name: Atenolol


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: temporal arteritis


subject: CHEBI:119486

subject_name: Efavirenz

object_name: HIV infection


subject: CHEBI:46295

subject_name: Vardenafil

object_name: impotence


subject: CHEBI:64312

subject_name: Memantine

object_name: Alzheimer disease


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Hodgkin Disease


subject: CHEBI:69478

subject_name: Cannabidiol

object_name: epilepsy


subject: CHEBI:44185

subject_name: Methotrexate

object_name: acute lymphoblastic leukemia


subject: CHEBI:63613

subject_name: Nevirapine


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Myelodysplasia


subject: CHEBI:7936

subject_name: Paroxetine

object_name: anxiety


subject: UNII:31YO63LBSN

subject_name: Nivolumab

object_name: metastatic melanoma


subject: UNII:31YO63LBSN

object_name: lung cancer


subject: CHEBI:82720

subject_name: Empagliflozin

object_name: diabetes mellitus


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: systemic mastocytosis


subject: CHEBI:44185

object_name: psoriasis


subject: CHEBI:7931

subject_name: Paricalcitol

object_name: secondary hyperparathyroidism


subject: CHEBI:39112

subject_name: Bosutinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: pneumonia


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: myasthenia gravis


subject: CHEBI:5931

subject_name: insulin human

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: emphysema


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Fever


subject: CHEBI:8707

subject_name: Quetiapine

object_name: schizophrenia


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: migraine


subject: CHEBI:7476

subject_name: Naproxen

object_name: Headache


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: melanoma


subject: CHEBI:49668

subject_name: Gefitinib

object_name: non-small cell lung carcinoma


subject: CHEBI:184555

subject_name: Xylan Sulfate

object_name: interstitial cystitis


subject: CHEBI:3347

subject_name: Candesartan

object_name: hypertension


subject: CHEBI:8871

subject_name: Risperidone

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:31YO63LBSN

subject_name: Nivolumab

object_name: Stomach cancer


subject: CHEBI:85973

subject_name: Edoxaban

object_name: atrial fibrillation


subject: CHEBI:3207

subject_name: Budesonide

object_name: asthma


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Allergy


subject: CHEBI:4681

subject_name: Dofetilide


subject: PUBCHEM.COMPOUND:3086655


subject: CHEBI:8772

subject_name: Raloxifene

object_name: osteoporosis


subject: CHEBI:167707

subject_name: Acalabrutinib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:76010

subject_name: Dolutegravir

object_name: HIV infection


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: psoriatic arthritis


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Ischemic stroke


subject: UNII:5W8JGG2651

subject_name: Idursulfase

object_name: Hunter Syndrome


subject: UNII:53AXN4NNHX

subject_name: semaglutide

object_name: diabetes mellitus


subject: CHEBI:82960

subject_name: Raltegravir


subject: CHEBI:7476

subject_name: Naproxen

object_name: arthritis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: osteoarthritis


subject: CHEBI:85010

subject_name: Eltrombopag

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:8871

subject_name: Risperidone

object_name: psychosis


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Plexosarcoma


subject: CHEBI:231425

subject_name: tolvaptan

object_name: polycystic kidney disease


subject: CHEBI:64028

subject_name: Tetrabenazine

object_name: Huntington disease


subject: CHEBI:72297

subject_name: Lomitapide

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:521033

subject_name: Dutasteride

object_name: benign prostatic hyperplasia


subject: UNII:9XW757O13D

subject_name: Ripretinib


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: ulcerative colitis


subject: UNII:513P80B4YJ

subject_name: Avapritinib


subject: CHEBI:8107

subject_name: Phenytoin

object_name: epilepsy


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab


subject: CHEBI:36795

subject_name: Duloxetine

object_name: fibromyalgia


subject: CHEBI:68610

subject_name: Linagliptin

object_name: type 2 diabetes mellitus


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: triple-negative breast carcinoma


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: migraine


subject: CHEBI:50659

subject_name: Dronedarone

object_name: atrial fibrillation


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: hyperlipidemia


subject: CHEBI:76018

subject_name: Riociguat

object_name: pulmonary hypertension


subject: HMDB:HMDB0253501

subject_name: Insulin degludec


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: colorectal cancer


subject: UNII:2S9ZZM9Q9V

object_name: psoriatic arthritis


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: sinusitis


subject: CHEBI:8888

subject_name: Ropinirole

object_name: Restless legs


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: dyspepsia


subject: CHEBI:70735

subject_name: Lurasidone

object_name: bipolar disorder


subject: UNII:59UA429E5G

subject_name: Galsulfase

object_name: mucopolysaccharidosis type 6


subject: UNII:2S9ZZM9Q9V

object_name: liver carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: non-small cell lung carcinoma


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Urinary Urgency


subject: UNII:RR6P8L282I

subject_name: Siponimod

object_name: multiple sclerosis


subject: CHEBI:8499

subject_name: Propranolol

object_name: hemangioma


subject: CHEBI:31524

subject_name: Droxidopa

object_name: Parkinson disease


subject: CHEBI:3756

subject_name: Clonazepam

object_name: anxiety


subject: CHEBI:7735

subject_name: Olanzapine

object_name: psychosis


subject: CHEBI:3766

subject_name: Clozapine

object_name: schizoaffective disorder


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: hyperlipidemia


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:7476

subject_name: Naproxen

object_name: Arthralgia


subject: CHEBI:40279

subject_name: Allopurinol

object_name: gout


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: asthma


subject: CHEBI:6538

subject_name: Loratadine

object_name: Hay fever


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase

object_name: acute lymphoblastic leukemia


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Fever


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: psoriasis


subject: CHEBI:82701

subject_name: Idelalisib

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: colorectal cancer


subject: CHEBI:44185

subject_name: Methotrexate

object_name: psoriatic arthritis


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: chronic obstructive pulmonary disease


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: liver carcinoma


subject: UNII:GK1LYB375A

subject_name: Tralokinumab

object_name: atopic eczema


subject: CHEBI:95341

subject_name: Baricitinib

object_name: rheumatoid arthritis


subject: CHEBI:68642

subject_name: Abiraterone

object_name: metastatic prostate carcinoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: mantle cell lymphoma


subject: CHEBI:6904

subject_name: Metoprolol

object_name: hypertension


subject: CHEBI:91083

subject_name: Romiplostim

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:9334

subject_name: Sulfasalazine


subject: CHEBI:64310

subject_name: Crizotinib

object_name: lung cancer


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: melanoma


subject: CHEBI:63791

object_name: follicular lymphoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:9150

subject_name: Simvastatin

object_name: hyperlipidemia


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Cystic acne


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:72564

subject_name: Temozolomide

object_name: glioblastoma


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: anxiety


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: metastatic melanoma


subject: CHEBI:3757

subject_name: Clonidine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:90936

subject_name: Alectinib


subject: CHEBI:7726

subject_name: octreotide

object_name: carcinoid tumor


subject: CHEBI:68551

subject_name: Linaclotide

object_name: irritable bowel syndrome


subject: UNII:76RS4S2ET1

subject_name: Risdiplam

object_name: spinal muscular atrophy


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: major depressive disorder


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: pulmonary fibrosis


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: myeloproliferative neoplasm


subject: CHEBI:2549

subject_name: Albuterol

object_name: Dyspnea


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: ovarian cancer


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: anemia


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: age-related macular degeneration


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:66743180

subject_name: Telotristat

object_name: carcinoid syndrome


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: psoriatic arthritis


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: dyspepsia


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: hypertrophic cardiomyopathy


subject: CHEBI:59173

subject_name: Bivalirudin

object_name: dry eye syndrome


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: Hashimoto thyroiditis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: lung cancer


subject: CHEBI:37924

subject_name: Atazanavir

object_name: HIV infection


subject: CHEBI:8707

subject_name: Quetiapine

object_name: sleep disorder


subject: CHEBI:367163

subject_name: Darunavir


subject: CHEBI:39867

subject_name: Valproic acid

object_name: epilepsy


subject: CHEBI:7931

subject_name: Paricalcitol

object_name: kidney disorder


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone

object_name: hypoparathyroidism


subject: CHEBI:8356

subject_name: Pramipexole

object_name: Parkinson disease


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: major depressive disorder


subject: CHEBI:134716

subject_name: Brexpiprazole


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: adult lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: non-Hodgkin lymphoma


subject: CHEBI:18050

subject_name: L-Glutamine

object_name: sickle cell disease


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: urinary tract infection


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: metastatic prostate carcinoma


subject: CHEBI:31524

subject_name: Droxidopa

object_name: autonomic neuropathy


subject: UNII:6T8C155666

subject_name: Ipilimumab

object_name: metastatic melanoma


subject: UNII:Y64GQ0KC0A

subject_name: Teprotumumab

object_name: endocrine exophthalmos


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Hypercholesterolemia


subject: CHEBI:6427

subject_name: Leuprolide

object_name: precocious puberty


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: thyroid tumor


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: diffuse large B-cell lymphoma


subject: CHEBI:49005

subject_name: Deferasirox


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: cystic fibrosis


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Hay fever


subject: CHEBI:6539

subject_name: Lorazepam

object_name: anxiety


subject: UNII:961YV2O515

subject_name: Efgartigimod alfa

object_name: myasthenia gravis


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Hyperuricemia


subject: CHEBI:75246

subject_name: Rifaximin

object_name: hepatic encephalopathy


subject: CHEBI:31348

subject_name: Capecitabine

object_name: colorectal cancer


subject: CHEBI:6437

subject_name: Levetiracetam

object_name: Partial Seizure


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Arthralgia


subject: UNII:P341G6W9NB

subject_name: Deutetrabenazine

object_name: tardive dyskinesia


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: bronchitis


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: psychosis


subject: CHEBI:31596

subject_name: Febuxostat

object_name: gout


subject: CHEBI:65346

subject_name: Aclidinium

object_name: chronic obstructive pulmonary disease


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: metastatic melanoma


subject: CHEBI:77260

subject_name: Omeprazole

object_name: dyspepsia


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: pulmonary hypertension


subject: CHEBI:7931

subject_name: Paricalcitol

object_name: kidney failure


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: epilepsy


subject: CHEBI:145499

subject_name: Donepezil

object_name: Alzheimer disease


subject: CHEBI:8888

subject_name: Ropinirole

object_name: Parkinson disease


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: acute lymphoblastic leukemia


subject: CHEBI:5062

subject_name: Finasteride

object_name: Frontal balding


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: glaucoma


subject: CHEBI:6775

subject_name: Mesalazine

object_name: Crohn disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: granulomatosis with polyangiitis


subject: CHEBI:68556

subject_name: Icatibant

object_name: hereditary angioedema


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: acromegaly


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: familial hypercholesterolemia


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: non-small cell lung carcinoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: myocardial infarction


subject: CHEBI:135901

subject_name: lanreotide


subject: UNII:4F4X42SYQ6

object_name: multiple sclerosis


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: diabetes mellitus


subject: CHEBI:36795

subject_name: Duloxetine

object_name: major depressive disorder


subject: CHEBI:3766

subject_name: Clozapine

object_name: psychosis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Arthralgia


subject: CHEBI:85164

subject_name: Nintedanib

object_name: interstitial lung disease


subject: CHEBI:3441

subject_name: Carvedilol

object_name: hypertension


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stomach cancer


subject: CHEBI:50663

subject_name: Zanamivir

object_name: influenza


subject: CHEBI:15544

subject_name: Alprostadil

object_name: impotence


subject: CHEBI:2637

subject_name: Amikacin

object_name: Mycobacterium avium complex disease


subject: UNII:U59UGK3IPC

subject_name: Ublituximab


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: epilepsy


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: uterine cancer


subject: CHEBI:28918

subject_name: Epinephrine

object_name: anaphylaxis


subject: CHEBI:4470

subject_name: Dextromethorphan

object_name: Cough


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:7735

subject_name: Olanzapine

object_name: Depressed mood


subject: CHEBI:63620

subject_name: Rasagiline

object_name: Parkinson disease


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Weight loss


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: sinusitis


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Chronic uremia


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:50922

subject_name: Eletriptan

object_name: migraine


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: EXCESS LMW-DNA


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:64310

subject_name: Crizotinib

object_name: non-small cell lung carcinoma


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: rheumatoid arthritis


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:144551

subject_name: Oxybutynin

object_name: Urinary Urgency


subject: CHEBI:7565

subject_name: Nifedipine

object_name: hypertension


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: CHEBI:71940

subject_name: Tadalafil

object_name: pulmonary hypertension


subject: CHEBI:47426

subject_name: Furosemide

object_name: heart failure


subject: UNII:U782C039QP

subject_name: GLATIRAMER

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:31348

subject_name: Capecitabine

object_name: cancer


subject: CHEBI:6437

subject_name: Levetiracetam

object_name: Bilateral tonic-clonic seizure


subject: CHEBI:51043

subject_name: Tegaserod

object_name: irritable bowel syndrome


subject: CHEBI:5775

subject_name: Hydralazine


subject: CHEBI:78538

object_name: amyloidosis


subject: CHEBI:134677

subject_name: Crisaborole

object_name: atopic eczema


subject: CHEBI:31941

subject_name: Oxaliplatin

object_name: colorectal cancer


subject: CHEBI:31355

subject_name: Carboplatin

object_name: lung cancer


subject: UNII:70BSQ12069

subject_name: Lumateperone

object_name: bipolar disorder


subject: CHEBI:36795

subject_name: Duloxetine

object_name: anxiety


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: mantle cell lymphoma


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:601027

subject_name: Aliskiren


subject: CHEBI:50694

subject_name: Minocycline

object_name: acne


subject: CHEBI:71415

subject_name: Nitrofurantoin

object_name: urinary tract infection


subject: CHEBI:3723

subject_name: Citalopram


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB

object_name: triple-negative breast carcinoma


subject: CHEBI:75998

subject_name: Trametinib

object_name: melanoma


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Depressed mood


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: glioblastoma


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: Crohn disease


subject: CHEBI:42797

subject_name: Gabapentin

object_name: fibromyalgia


subject: CHEBI:16469

subject_name: Estradiol

object_name: Hot flashes


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: Heartburn


subject: CHEBI:94686

subject_name: Orlistat

object_name: Weight loss


subject: CHEBI:61390

subject_name: Afatinib

object_name: non-small cell lung carcinoma


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: temporal arteritis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: inherited lipid metabolism disorder


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: thyroid tumor


subject: CHEBI:8382

subject_name: Prednisone

object_name: rheumatoid arthritis


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: adult lymphoma


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Limb pain


subject: CHEBI:45783

subject_name: Imatinib

object_name: acute lymphoblastic leukemia


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Myelodysplasia


subject: CHEBI:7726

subject_name: octreotide

object_name: carcinoid syndrome


subject: CHEBI:10125

subject_name: Zolpidem

object_name: sleep disorder


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: stroke disorder


subject: CHEBI:70707

subject_name: Vilazodone

object_name: Depressed mood


subject: CHEBI:177453

subject_name: Elagolix

object_name: endometriosis


subject: CHEBI:85993

subject_name: Palbociclib

object_name: cancer


subject: CHEBI:63916

subject_name: Iloprost

object_name: pulmonary hypertension


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: glucose intolerance


subject: CHEBI:4708

subject_name: Doxazosin

object_name: hypertension


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: trigeminal neuralgia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: follicular lymphoma


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: retinal vein occlusion


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: leukopenia


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: migraine


subject: CHEBI:6970

subject_name: Mometasone

object_name: asthma


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: pneumonia


subject: CHEBI:196955

subject_name: Atogepant


subject: CHEBI:8499

subject_name: Propranolol

object_name: capillary infantile hemangioma


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate


subject: UNII:P85X70RZWS

subject_name: Cenobamate

object_name: epilepsy


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: graft versus host disease


subject: CHEBI:4551

subject_name: Digoxin

object_name: atrial fibrillation


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin

object_name: diffuse large B-cell lymphoma


subject: UNII:Z80293URPV

subject_name: Ozanimod

object_name: ulcerative colitis


subject: CHEBI:64356

subject_name: Pregabalin

object_name: postherpetic neuralgia


subject: CHEBI:10110

subject_name: Zidovudine

object_name: HIV infection


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:71253

subject_name: asenapine

object_name: bipolar disorder


subject: CHEBI:90844

subject_name: Selexipag

object_name: pulmonary hypertension


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: hypercholesterolemia, familial, 1


subject: UNII:LMQ24G57E9

subject_name: Daridorexant

object_name: insomnia


subject: CHEBI:64019

subject_name: Nebivolol

object_name: hypertension


subject: CHEBI:42797

subject_name: Gabapentin

object_name: diabetic neuropathy


subject: CHEBI:17347

subject_name: Testosterone

object_name: hypogonadism


subject: CHEBI:71193

subject_name: Liraglutide

object_name: diabetes mellitus


subject: CHEBI:85010

subject_name: Eltrombopag

object_name: thrombocytopenia


subject: CHEBI:9448

subject_name: Terbinafine

object_name: tinea unguium


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: small cell lung carcinoma


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: essential thrombocythemia


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: endometrial cancer


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: hyperlipidemia


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Allergy


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: lung cancer


subject: CHEBI:135351

subject_name: Rotigotine

object_name: Restless legs


subject: CHEBI:135515

subject_name: Bendamustine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:28680

subject_name: Cytarabine

object_name: acute lymphoblastic leukemia


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: colorectal cancer


subject: CHEBI:8378

subject_name: Prednisolone

object_name: rheumatoid arthritis


subject: CHEBI:72292

subject_name: Bedaquiline

object_name: tuberculosis


subject: CHEBI:8871

subject_name: Risperidone

object_name: schizoaffective disorder


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: hypersomnia


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: Urinary Urgency


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: diabetic retinopathy


subject: CHEBI:63616

subject_name: Pemetrexed


subject: UNII:DPT0O3T46P

object_name: transitional cell carcinoma


subject: CHEBI:90936

subject_name: Alectinib

object_name: non-small cell lung carcinoma


subject: CHEBI:8707

subject_name: Quetiapine

object_name: anxiety


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Myelodysplasia


subject: CHEBI:49668

subject_name: Gefitinib


subject: UNII:12PYH0FTU9

subject_name: Lecanemab

object_name: Alzheimer disease


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:231350

subject_name: Pacritinib

object_name: myelofibrosis


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Still Disease


subject: CHEBI:135720

subject_name: Deflazacort

object_name: muscular dystrophy


subject: CHEBI:8707

object_name: insomnia


subject: UNII:23HYE36B0I

subject_name: Velaglucerase alfa

object_name: Gaucher disease


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Turner syndrome


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:109549

subject_name: Ramelteon


subject: PUBCHEM.COMPOUND:3367

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:31413

subject_name: Clobazam

object_name: epilepsy


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Osteopenia


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: arteriosclerosis disorder


subject: CHEBI:15940

subject_name: Niacin

object_name: familial hypercholesterolemia


subject: CHEBI:4875

subject_name: Etanercept

object_name: arthritis


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: atopic eczema


subject: UNII:R581OT55EA

subject_name: PEG-uricase

object_name: gout


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Cushing syndrome


subject: UNII:87PZU03K0K

subject_name: Ferric oxyhydroxide

object_name: iron deficiency anemia


subject: CHEBI:68610

subject_name: Linagliptin

object_name: diabetes mellitus


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: psoriasis


subject: CHEBI:4784

subject_name: Enalapril

object_name: hypertension


subject: CHEBI:10023

subject_name: Voriconazole

object_name: aspergillosis


subject: CHEBI:9241

subject_name: Spironolactone


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: plasma cell myeloma


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: prostatitis


subject: CHEBI:63607

subject_name: Linezolid

object_name: staphylococcal infection


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: stroke disorder


subject: UNII:N0A21N6RAU

subject_name: Deucravacitinib


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: neuromyelitis optica


subject: CHEBI:71193

subject_name: Liraglutide

object_name: Weight loss


subject: CHEBI:3175

subject_name: Brimonidine

object_name: glaucoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: acute lymphoblastic leukemia


subject: CHEBI:135720

subject_name: Deflazacort

object_name: Duchenne muscular dystrophy


subject: UNII:AIW6036FAS

subject_name: Eteplirsen


subject: UNII:PTB4X93HE1

subject_name: Maribavir

object_name: cytomegalovirus infection


subject: CHEBI:133013

subject_name: Brivaracetam

object_name: epilepsy


subject: CHEBI:28925

subject_name: Mechlorethamine

object_name: mycosis fungoides


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: anxiety


subject: CHEBI:135005

subject_name: Milnacipran

object_name: fibromyalgia


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: ankylosing spondylitis


subject: CHEBI:47657

subject_name: Roflumilast

object_name: chronic obstructive pulmonary disease


subject: CHEBI:9622

subject_name: Tolterodine

object_name: Urinary Urgency


subject: CHEBI:50730

subject_name: Montelukast

object_name: Allergy


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: postmenopausal osteoporosis


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: amyloidosis


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Depressed mood


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: Dravet syndrome


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: juvenile idiopathic arthritis


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Crohn disease


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: major depressive disorder


subject: CHEBI:4798

subject_name: Entacapone

object_name: Parkinson disease


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: psoriatic arthritis


subject: CHEBI:142418

subject_name: Vibegron


subject: CHEBI:32229

subject_name: Tiopronin

object_name: cystinuria


subject: CHEBI:134700

subject_name: Etelcalcetide

object_name: secondary hyperparathyroidism


subject: CHEBI:2549

subject_name: Albuterol

object_name: Wheezing


subject: UNII:53AXN4NNHX

subject_name: semaglutide

object_name: Weight loss


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: ovarian cancer


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: atopic eczema


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: bipolar disorder


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: bacterial infectious disease


subject: CHEBI:76612

subject_name: Ibrutinib

object_name: non-Hodgkin lymphoma


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: type 2 diabetes mellitus


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:3001

subject_name: beclomethasone

object_name: asthma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: substance abuse


subject: CHEBI:27899

subject_name: Cisplatin

object_name: non-small cell lung carcinoma


subject: CHEBI:5062

subject_name: Finasteride

object_name: benign prostatic hyperplasia


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: plasma cell myeloma


subject: CHEBI:47381

subject_name: Diclofenac

object_name: osteoarthritis


subject: CHEBI:31174

subject_name: Adapalene

object_name: Cystic acne


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: interstitial lung disease


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: arthritis


subject: CHEBI:8707

subject_name: Quetiapine

object_name: psychosis


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Hodgkin Disease


subject: UNII:4G86Y4JT3F

subject_name: Baloxavir

object_name: influenza


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: hidradenitis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: chronic graft versus host disease


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: hypertension


subject: CHEBI:133021

subject_name: Venetoclax


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: melanoma


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: retinal vein occlusion


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: Lennox-Gastaut syndrome


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: acute coronary syndrome


subject: CHEBI:7476

subject_name: Naproxen

object_name: Dysmenorrhea


subject: CHEBI:31941

subject_name: Oxaliplatin

object_name: Stomach cancer


subject: UNII:54534MX6Z9

subject_name: Teclistamab

object_name: plasma cell myeloma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: macular degeneration


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: rheumatoid arthritis


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: EXCESS LMW-DNA


subject: CHEBI:6923

subject_name: Miconazole

object_name: Mycoses


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Pemphigoid


subject: CHEBI:36795

subject_name: Duloxetine

object_name: neuralgia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: bronchitis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: lung cancer


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:10127

subject_name: Zonisamide

object_name: epilepsy


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: dyspepsia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:64064

subject_name: Salmeterol

object_name: asthma


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: psoriasis


subject: CHEBI:49575

subject_name: Diazepam

object_name: anxiety


subject: CHEBI:85980

subject_name: Eluxadoline

object_name: irritable bowel syndrome


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: acute myocardial infarction


subject: CHEBI:28077

subject_name: Rifampin

object_name: tuberculosis


subject: CHEBI:10033

subject_name: Warfarin

object_name: pulmonary embolism


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: non-small cell lung carcinoma


subject: CHEBI:85164

subject_name: Nintedanib

object_name: pulmonary fibrosis


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Allergy


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Prader-Willi syndrome


subject: CHEBI:5383

subject_name: Glimepiride

object_name: diabetes mellitus


subject: UNII:AD0O8X2QJR

subject_name: Ubrogepant

object_name: migraine


subject: CHEBI:8707

subject_name: Quetiapine

object_name: bipolar I disorder


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: heart failure


subject: CHEBI:7852

subject_name: Oxycodone

object_name: substance abuse


subject: CHEBI:6538

subject_name: Loratadine

object_name: Rhinorrhea


subject: CHEBI:82975

subject_name: Naloxegol

object_name: Constipation


subject: CHEBI:31236

subject_name: Aripiprazole


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: non-Hodgkin lymphoma


subject: CHEBI:78540

subject_name: Apremilast

object_name: rheumatoid arthritis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: arthritis


subject: CHEBI:48273

subject_name: Rizatriptan


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Recurrent lower respiratory tract infections


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Hay fever


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: anxiety


subject: CHEBI:75246

subject_name: Rifaximin

object_name: liver cirrhosis


subject: CHEBI:28864

subject_name: Tobramycin

object_name: bronchiectasis


subject: CHEBI:2549

subject_name: Albuterol

object_name: bronchitis


subject: CHEBI:9123

subject_name: Sertraline

object_name: Compulsion


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: myocardial infarction


subject: CHEBI:69478

subject_name: Cannabidiol

object_name: Partial Seizure


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: hyperlipidemia


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: chronic kidney disease


subject: CHEBI:46081

subject_name: Fluconazole

object_name: Mycoses


subject: CHEBI:5384

subject_name: Glipizide

object_name: diabetes mellitus


subject: CHEBI:5613

subject_name: Haloperidol

object_name: schizophrenia


subject: CHEBI:3892

subject_name: Corticotropin

object_name: sarcoidosis


subject: CHEBI:9654

subject_name: Trazodone

object_name: insomnia


subject: PUBCHEM.COMPOUND:66743180

subject_name: Telotristat

object_name: carcinoid tumor


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:38940

subject_name: Sunitinib

object_name: renal cell carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: triple-negative breast carcinoma


subject: CHEBI:76612

subject_name: Ibrutinib

object_name: lymphoid leukemia


subject: CHEBI:8871

subject_name: Risperidone

object_name: Atypical behavior


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:32127

subject_name: sevelamer

object_name: hyperphosphatemia


subject: CHEBI:188986

subject_name: idose

object_name: glaucoma


subject: CHEBI:68540

subject_name: Teriflunomide

object_name: relapsing-remitting multiple sclerosis


subject: HMDB:HMDB0253501

subject_name: Insulin degludec

object_name: type 1 diabetes mellitus 1


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Growth delay


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: Still Disease


subject: CHEBI:3207

subject_name: Budesonide

object_name: chronic obstructive pulmonary disease


subject: CHEBI:229661

subject_name: Omaveloxolone

object_name: Friedreich ataxia


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: inflammatory bowel disease


subject: CHEBI:10124

subject_name: Zolmitriptan

object_name: migraine


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Crohn disease


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Mycoses


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: Dyspnea


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: inherited lipid metabolism disorder


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: acute lymphoblastic leukemia


subject: CHEBI:2663

subject_name: Amiodarone

object_name: ventricular tachycardia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: vasculitis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: liver carcinoma


subject: CHEBI:64356

subject_name: Pregabalin

object_name: herpes zoster


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: ptosis


subject: CHEBI:232810

subject_name: Brigatinib

object_name: non-small cell lung carcinoma


subject: UNII:0KVO411B3N

subject_name: tislelizumab

object_name: lung cancer


subject: CHEBI:2663

object_name: Arrhythmia


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: colitis


subject: CHEBI:77733

subject_name: Verapamil

object_name: hypertension


subject: CHEBI:2611

subject_name: Alprazolam

object_name: Depressed mood


subject: CHEBI:8871

subject_name: Risperidone

object_name: Aggressive behavior


subject: CHEBI:31355

subject_name: Carboplatin

object_name: triple-negative breast carcinoma


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: neuromyelitis optica


subject: CHEBI:7936

subject_name: Paroxetine

object_name: panic disorder


subject: CHEBI:143658


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Limb pain


subject: UNII:F94OW58Y8V

subject_name: AZITHROMYCIN, UNSPECIFIED FORM

object_name: pneumonia


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: major depressive disorder


subject: CHEBI:391960

subject_name: Darifenacin

object_name: Urinary Urgency


subject: UNII:NWQ5N31VKK

subject_name: Daptomycin

object_name: staphylococcal infection


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: multiple sclerosis


subject: CHEBI:230905

subject_name: Ribociclib

object_name: hormone receptor-positive breast cancer


subject: CHEBI:51380

subject_name: Doxylamine

object_name: insomnia


subject: UNII:31YO63LBSN

subject_name: Nivolumab

object_name: head and neck squamous cell carcinoma


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: eosinophilic granulomatosis with polyangiitis


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: atypical hemolytic-uremic syndrome


subject: CHEBI:9123

subject_name: Sertraline


subject: UNII:5Q6TZN2HNM

subject_name: Ecallantide

object_name: hereditary angioedema


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: cystitis


subject: CHEBI:3732

subject_name: Clarithromycin


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: thrombotic microangiopathy


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: colorectal cancer


subject: CHEBI:135939

subject_name: Lacosamide

object_name: Partial Seizure


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: transient ischemic attack


subject: CHEBI:27899

subject_name: Cisplatin

object_name: Stomach cancer


subject: CHEBI:90933

subject_name: Cariprazine

object_name: bipolar disorder


subject: CHEBI:82752

subject_name: Eliglustat

object_name: Gaucher disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: pemphigus


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: lung cancer


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b

object_name: acquired polycythemia vera


subject: CHEBI:84500

subject_name: varenicline

object_name: dry eye syndrome


subject: CHEBI:75998

subject_name: Trametinib

object_name: metastatic melanoma


subject: CHEBI:3219

subject_name: Bupropion

object_name: anxiety


subject: CHEBI:3175

subject_name: Brimonidine

object_name: rosacea


subject: CHEBI:142290

subject_name: Anagrelide

object_name: essential thrombocythemia


subject: CHEBI:37941

object_name: coronary artery disorder


subject: UNII:53AXN4NNHX

subject_name: semaglutide

object_name: glucose intolerance


subject: UNII:A3ULP0F556

object_name: neuromyelitis optica


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: CHEBI:5383

subject_name: Glimepiride

object_name: type 2 diabetes mellitus


subject: CHEBI:9150

subject_name: Simvastatin

object_name: inherited lipid metabolism disorder


subject: CHEBI:8499

subject_name: Propranolol

object_name: migraine


subject: CHEBI:7735

subject_name: Olanzapine

object_name: schizoaffective disorder


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: osteoarthritis


subject: UNII:GE2T1418SV

subject_name: Umeclidinium

object_name: chronic obstructive pulmonary disease


subject: CHEBI:15940

subject_name: Niacin

object_name: hyperlipidemia


subject: CHEBI:82720

subject_name: Empagliflozin

object_name: heart failure


subject: CHEBI:7931

subject_name: Paricalcitol

object_name: Chronic uremia


subject: CHEBI:65349

subject_name: Mirabegron

object_name: Urinary incontinence


subject: CHEBI:71013

subject_name: Perampanel

object_name: epilepsy


subject: CHEBI:31596

subject_name: Febuxostat

object_name: Hyperuricemia


subject: CHEBI:47426

subject_name: Furosemide

object_name: Edema


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Hyponatremia


subject: CHEBI:133021

subject_name: Venetoclax

object_name: mantle cell lymphoma


subject: CHEBI:91083

subject_name: Romiplostim

object_name: thrombocytopenia


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:2618

subject_name: Amantadine

object_name: Parkinson disease


subject: CHEBI:36795

subject_name: Duloxetine

object_name: diabetic neuropathy


subject: CHEBI:63608

subject_name: Maraviroc

object_name: HIV infection


subject: UNII:6T8C155666

subject_name: Ipilimumab

object_name: non-small cell lung carcinoma


subject: UNII:31YO63LBSN

subject_name: Nivolumab

object_name: liver carcinoma


subject: CHEBI:27882

subject_name: Colchicine

object_name: gout


subject: CHEBI:78432

subject_name: Ceritinib


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Myelodysplasia


subject: CHEBI:5893

subject_name: Indapamide

object_name: hypertension


subject: CHEBI:6030

subject_name: Isoniazid

object_name: tuberculosis


subject: CHEBI:95341

subject_name: Baricitinib

object_name: alopecia areata


subject: CHEBI:8382

subject_name: Prednisone

object_name: diffuse large B-cell lymphoma


subject: CHEBI:50173

subject_name: Acitretin

object_name: psoriasis


subject: UNII:87PZU03K0K

subject_name: Ferric oxyhydroxide

object_name: anemia


subject: CHEBI:15367

subject_name: Tretinoin

object_name: acute promyelocytic leukemia


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: small cell lung carcinoma


subject: CHEBI:51043

subject_name: Tegaserod

object_name: Constipation


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: non-Hodgkin lymphoma


subject: CHEBI:3892

subject_name: Corticotropin

object_name: nephrotic syndrome


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: macular degeneration


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: chronic bronchitis


subject: CHEBI:29688

subject_name: Telithromycin

object_name: sinusitis


subject: CHEBI:3892

object_name: multiple sclerosis


subject: CHEBI:75246

subject_name: Rifaximin

object_name: irritable bowel syndrome


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: arthritis


subject: CHEBI:50924

subject_name: Sorafenib

object_name: renal cell carcinoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Limb pain


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Allergy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:70735

subject_name: Lurasidone

object_name: schizophrenia


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: juvenile idiopathic arthritis


subject: CHEBI:63607

subject_name: Linezolid

object_name: tuberculosis


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: hyperlipidemia


subject: CHEBI:3766

subject_name: Clozapine

object_name: bipolar disorder


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: pneumonia


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: chronic hepatitis B virus infection


subject: CHEBI:232810

subject_name: Brigatinib

object_name: lung cancer


subject: CHEBI:2453

subject_name: Acyclovir

object_name: genital herpes


subject: CHEBI:101085

subject_name: Diclofenamide

object_name: familial periodic paralysis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:421707

subject_name: Abacavir

object_name: HIV infection


subject: UNII:31YO63LBSN

subject_name: Nivolumab

object_name: Hodgkin Disease


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: EXCESS LMW-DNA


subject: CHEBI:7476

subject_name: Naproxen

object_name: migraine


subject: CHEBI:228304

subject_name: Vamorolone

object_name: Duchenne muscular dystrophy


subject: CHEBI:63925

subject_name: PhXa 85

object_name: Ocular hypertension


subject: CHEBI:60799

subject_name: Esketamine

object_name: major depressive disorder


subject: CHEBI:4875

subject_name: Etanercept

object_name: Polyarthritis


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: chronic urticaria


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: nephrotic syndrome


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Breakthrough pain


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4551

subject_name: Digoxin

object_name: heart disorder


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: diverticulitis


subject: CHEBI:64356

subject_name: Pregabalin

object_name: trigeminal neuralgia


subject: CHEBI:5558

subject_name: Guanfacine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:90863

subject_name: Sonidegib

object_name: basal cell carcinoma


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: Headache


subject: CHEBI:38940

subject_name: Sunitinib

object_name: cancer


subject: CHEBI:71940

subject_name: Tadalafil

object_name: benign prostatic hyperplasia


subject: CHEBI:10650

subject_name: Sumatriptan


subject: CHEBI:17141

subject_name: Cysteamine

object_name: cystinosis


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: granulomatosis with polyangiitis


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: acute myocardial infarction


subject: CHEBI:143117

subject_name: Lorlatinib

object_name: non-small cell lung carcinoma


subject: CHEBI:6427

subject_name: Leuprolide

object_name: metastatic prostate carcinoma


subject: CHEBI:64356

object_name: sciatica


subject: CHEBI:31355

subject_name: Carboplatin

object_name: small cell lung carcinoma


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: digestive system disorder


subject: CHEBI:135888

subject_name: Pimecrolimus

object_name: atopic eczema


subject: CHEBI:8378

subject_name: Prednisolone

object_name: EXCESS LMW-DNA


subject: CHEBI:85990

subject_name: Panobinostat

object_name: plasma cell myeloma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: epilepsy


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: anxiety


subject: CHEBI:36791

subject_name: Escitalopram

object_name: major depressive disorder


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: Common Migraine


subject: CHEBI:4975

subject_name: Famotidine

object_name: Heartburn


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Parkinson disease


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: acne


subject: CHEBI:71253

subject_name: asenapine

object_name: schizophrenia


subject: CHEBI:65349

subject_name: Mirabegron

object_name: Pollakisuria


subject: CHEBI:47381

subject_name: Diclofenac

object_name: rheumatoid arthritis


subject: UNII:2R27AB6766

subject_name: Caplacizumab

object_name: thrombotic microangiopathy


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: pulmonary embolism


subject: CHEBI:44185

subject_name: Methotrexate

object_name: primary central nervous system lymphoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: chronic kidney disease


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: psoriatic arthritis


subject: CHEBI:61390

subject_name: Afatinib

object_name: lung cancer


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Urinary incontinence


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: myelofibrosis


subject: CHEBI:36795

subject_name: Duloxetine

object_name: peripheral nervous system disorder


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Still Disease


subject: UNII:DLG4EML025

subject_name: Secukinumab


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Stomach cancer


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: chronic graft versus host disease


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: triple-negative breast carcinoma


subject: CHEBI:3219

subject_name: Bupropion

object_name: major depressive disorder


subject: CHEBI:15365

subject_name: Aspirin

object_name: coronary artery disorder


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Myelodysplasia


subject: CHEBI:64356

subject_name: Pregabalin

object_name: anxiety


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: inherited lipid metabolism disorder


subject: CHEBI:3756

subject_name: Clonazepam

object_name: insomnia


subject: CHEBI:8382

subject_name: Prednisone

object_name: EXCESS LMW-DNA


subject: CHEBI:49005

subject_name: Deferasirox

object_name: thalassemia


subject: CHEBI:44185

subject_name: Methotrexate

object_name: juvenile idiopathic arthritis


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: schizophrenia


subject: CHEBI:83804

subject_name: Paliperidone

object_name: bipolar disorder


subject: CHEBI:50378

subject_name: Nitisinone

object_name: tyrosinemia


subject: CHEBI:70839

subject_name: Dasatinib

object_name: leukemia


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: urinary tract infection


subject: CHEBI:6801

subject_name: Metformin

object_name: heart failure


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:31859

subject_name: Modafinil

object_name: narcolepsy


subject: CHEBI:94449

subject_name: Glycopyrronium

object_name: chronic obstructive pulmonary disease


subject: UNII:LR3UXN0193

subject_name: Methoxy polyethylene glycol-epoetin beta

object_name: anemia


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:490877

subject_name: Didanosine

object_name: HIV infection


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: major depressive disorder


subject: CHEBI:52717

subject_name: Bortezomib

object_name: mantle cell lymphoma


subject: CHEBI:6909

subject_name: Metronidazole

object_name: rosacea


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: ankylosing spondylitis


subject: CHEBI:63581

subject_name: Stavudine


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: head and neck squamous cell carcinoma


subject: UNII:F94OW58Y8V

subject_name: AZITHROMYCIN, UNSPECIFIED FORM

object_name: bronchitis


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: contact dermatitis


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: pancreatic adenocarcinoma


subject: CHEBI:31941

subject_name: Oxaliplatin

object_name: gastric adenocarcinoma


subject: CHEBI:28077

subject_name: Rifampin

object_name: pulmonary tuberculosis


subject: CHEBI:143117

subject_name: Lorlatinib

object_name: lung cancer


subject: HMDB:HMDB0253501

subject_name: Insulin degludec

object_name: diabetes mellitus


subject: CHEBI:63631

subject_name: Topiramate

object_name: Headache


subject: CHEBI:2618

subject_name: Amantadine

object_name: Dyskinesia


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Partial Seizure


subject: UNII:F94OW58Y8V


subject: CHEBI:49960

subject_name: Vandetanib

object_name: thyroid tumor


subject: CHEBI:8871

subject_name: Risperidone

object_name: anxiety


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: migraine


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Arthralgia


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: psoriasis


subject: UNII:420K487FSG

object_name: chronic rhinosinusitis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: cancer


subject: CHEBI:50131

subject_name: Decitabine

object_name: Myelodysplasia


subject: CHEBI:4975

subject_name: Famotidine

object_name: dyspepsia


subject: CHEBI:228488

subject_name: Stiripentol

object_name: Dravet syndrome


subject: CHEBI:8382

subject_name: Prednisone

object_name: asthma


subject: UNII:NWQ5N31VKK

subject_name: Daptomycin

object_name: osteomyelitis


subject: CHEBI:7735

subject_name: Olanzapine


subject: UNII:GR88G0I6UL

subject_name: IPRATROPIUM

object_name: chronic obstructive pulmonary disease


subject: UNII:J697UZ2A9J

subject_name: IPRATROPIUM BROMIDE


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:28925

subject_name: Mechlorethamine

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:135515

subject_name: Bendamustine

object_name: non-Hodgkin lymphoma


subject: CHEBI:63589

subject_name: Etravirine

object_name: HIV infection


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: diffuse large B-cell lymphoma


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: digestive system disorder


subject: CHEBI:76612

subject_name: Ibrutinib

object_name: adult lymphoma


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: atopic eczema


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:95341

subject_name: Baricitinib


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: age-related macular degeneration


subject: CHEBI:76612


subject: UNII:31YO63LBSN

subject_name: Nivolumab


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: bronchitis


subject: CHEBI:83804

subject_name: Paliperidone

object_name: psychosis


subject: CHEBI:3561

subject_name: Cetirizine

object_name: urticaria


subject: CHEBI:63619

subject_name: Propafenone

object_name: atrial fibrillation


subject: CHEBI:71219

subject_name: Pazopanib

object_name: cancer


subject: UNII:31YO63LBSN

object_name: small cell lung carcinoma


subject: CHEBI:6076

subject_name: Itraconazole

object_name: tinea unguium


subject: CHEBI:3892

subject_name: Corticotropin

object_name: EXCESS LMW-DNA


subject: CHEBI:6801

subject_name: Metformin

object_name: Androgen excess


subject: CHEBI:42797

subject_name: Gabapentin

object_name: bipolar disorder


subject: CHEBI:90933

subject_name: Cariprazine

object_name: bipolar I disorder


subject: CHEBI:47426

subject_name: Furosemide

object_name: Edema Limbs


subject: CHEBI:134699

subject_name: Opicapone

object_name: Parkinson disease


subject: CHEBI:5147

subject_name: Formoterol

object_name: asthma


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: diabetes mellitus


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Dysmenorrhea


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: psoriasis


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Compulsion


subject: CHEBI:87715

subject_name: Prasugrel

object_name: acute myocardial infarction


subject: CHEBI:77260

subject_name: Omeprazole

object_name: gastritis


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: indolent systemic mastocytosis


subject: CHEBI:178199

subject_name: Sotorasib

object_name: non-small cell lung carcinoma


subject: CHEBI:9241

subject_name: Spironolactone

object_name: heart failure


subject: CHEBI:7735

subject_name: Olanzapine


subject: CHEBI:135922

subject_name: Pramlintide

object_name: type 2 diabetes mellitus


subject: CHEBI:2948

subject_name: Azathioprine

object_name: ulcerative colitis


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: idiopathic urticaria


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: lupus nephritis


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: pulmonary embolism


subject: CHEBI:187893

subject_name: Baclofen

object_name: Muscle spasm


subject: CHEBI:5613

subject_name: Haloperidol

object_name: psychosis


subject: CHEBI:5855

object_name: Limb pain


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: insomnia


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Heartburn


subject: CHEBI:50673

subject_name: Methimazole

object_name: hyperthyroidism


subject: CHEBI:46081

subject_name: Fluconazole

object_name: candidiasis


subject: CHEBI:77260

object_name: digestive system disorder


subject: UNII:P341G6W9NB

subject_name: Deutetrabenazine

object_name: Huntington disease


subject: UNII:ROV204583W

subject_name: Givosiran

object_name: acute intermittent porphyria


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: urticaria


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: multiple sclerosis


subject: CHEBI:2453

subject_name: Acyclovir

object_name: herpes simplex


subject: CHEBI:2668

subject_name: Amlodipine

object_name: essential hypertension


subject: CHEBI:2549

subject_name: Albuterol

object_name: Cough


subject: UNII:DQ448MW7KS

subject_name: Palivizumab

object_name: bronchopulmonary dysplasia


subject: CHEBI:8707

subject_name: Quetiapine

object_name: schizoaffective disorder


subject: CHEBI:4450

subject_name: Desmopressin

object_name: diabetes insipidus


subject: CHEBI:2611

subject_name: Alprazolam


subject: CHEBI:51860

subject_name: Dexmethylphenidate

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:80630

subject_name: Irinotecan

object_name: colorectal cancer


subject: CHEBI:4875

subject_name: Etanercept

object_name: spondyloarthropathy


subject: CHEBI:31355

subject_name: Carboplatin

object_name: cancer


subject: UNII:420K487FSG

subject_name: Dupilumab


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: psoriasis


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Heartburn


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: alopecia areata


subject: CHEBI:52717

subject_name: Bortezomib

object_name: amyloidosis


subject: CHEBI:28876

subject_name: Melphalan

object_name: plasma cell myeloma


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Mycoses


subject: CHEBI:50730

subject_name: Montelukast

object_name: Atopic rhinitis


subject: CHEBI:42944

subject_name: Galantamine

object_name: Alzheimer disease


subject: CHEBI:3011

subject_name: Benazepril

object_name: hypertension


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: CHEBI:187893

subject_name: Baclofen

object_name: cerebral palsy


subject: CHEBI:42797

subject_name: Gabapentin

object_name: trigeminal neuralgia


subject: CHEBI:3176

subject_name: Brinzolamide

object_name: glaucoma


subject: CHEBI:50381

subject_name: Miglustat

object_name: Niemann-Pick disease


subject: CHEBI:64028

subject_name: Tetrabenazine

object_name: Dyskinesia


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Rhinorrhea


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Myelodysplasia


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: diabetic retinopathy


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Hay fever


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: inherited lipid metabolism disorder


subject: CHEBI:7476

subject_name: Naproxen

object_name: Limb pain


subject: CHEBI:3207

subject_name: Budesonide

object_name: Crohn disease


subject: CHEBI:64356

subject_name: Pregabalin

object_name: polyneuropathy


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Pollakisuria


subject: UNII:5YL4IQ1078

subject_name: Osilodrostat

object_name: Cushing Disease


subject: UNII:64FS3BFH5W

subject_name: EPOETIN

object_name: anemia


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:28304

subject_name: Heparin

object_name: pulmonary embolism


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Restless legs


subject: CHEBI:135929

subject_name: Silodosin

object_name: benign prostatic hyperplasia


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: ankylosing spondylitis


subject: CHEBI:3223

subject_name: Buspirone

object_name: anxiety


subject: CHEBI:4875

subject_name: Etanercept

object_name: osteoarthritis


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: juvenile idiopathic arthritis


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: motion sickness


subject: CHEBI:8707

subject_name: Quetiapine

object_name: major depressive disorder


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: adult lymphoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: fibromyalgia


subject: CHEBI:2950

subject_name: Azelastine

object_name: Allergy


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: bone giant cell tumor


subject: CHEBI:144551

subject_name: Oxybutynin

object_name: Urinary incontinence


subject: CHEBI:2469

subject_name: Adefovir

object_name: chronic hepatitis B virus infection


subject: CHEBI:31941

subject_name: Oxaliplatin

object_name: rectum adenocarcinoma


subject: CHEBI:39867

subject_name: Valproic acid

object_name: bipolar disorder


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: bipolar II disorder


subject: CHEBI:6539

subject_name: Lorazepam

object_name: insomnia


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:49005

subject_name: Deferasirox

object_name: beta thalassemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: primary central nervous system lymphoma


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: CHEBI:6775

subject_name: Mesalazine

object_name: colitis


subject: CHEBI:7931

subject_name: Paricalcitol

object_name: hyperparathyroidism


subject: CHEBI:6741

subject_name: Meloxicam

object_name: osteoarthritis


subject: CHEBI:44185

subject_name: Methotrexate

object_name: ectopic pregnancy


subject: CHEBI:9334

subject_name: Sulfasalazine

object_name: ulcerative colitis


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: coronary artery disorder


subject: CHEBI:91408

subject_name: Fedratinib

object_name: myelofibrosis


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: microscopic polyangiitis


subject: CHEBI:75984

subject_name: Flecainide

object_name: atrial fibrillation


subject: CHEBI:69478

subject_name: Cannabidiol

object_name: idiopathic generalized epilepsy


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: essential thrombocythemia


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: cancer


subject: CHEBI:82405

subject_name: Benzoyl peroxide

object_name: acne


subject: CHEBI:45863

object_name: Stomach cancer


subject: CHEBI:44185

object_name: arthritis


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: hidradenitis


subject: CHEBI:31401

subject_name: Cilostazol

object_name: stroke disorder


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: EXCESS LMW-DNA


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Limb pain


subject: CHEBI:3207

subject_name: Budesonide

object_name: Hematuria


subject: CHEBI:5931

subject_name: insulin human

object_name: type 1 diabetes mellitus


subject: CHEBI:87715

subject_name: Prasugrel

object_name: acute coronary syndrome


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: graft versus host disease


subject: CHEBI:38565

subject_name: Fluvastatin

object_name: Hypercholesterolemia


subject: UNII:87PZU03K0K

subject_name: Ferric oxyhydroxide

object_name: hyperphosphatemia


subject: CHEBI:2611

subject_name: Alprazolam

object_name: Panic attack


subject: CHEBI:176844

subject_name: Niraparib

object_name: peritoneum cancer


subject: CHEBI:42797

subject_name: Gabapentin

object_name: postherpetic neuralgia


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: Cough


subject: UNII:L7451S9126

subject_name: Crizanlizumab

object_name: sickle cell disease


subject: CHEBI:3756

subject_name: Clonazepam

object_name: epilepsy


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: myasthenia gravis


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: adrenocortical insufficiency


subject: CHEBI:4551

subject_name: Digoxin

object_name: heart failure


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: bipolar disorder


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: multiple sclerosis


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: bronchitis


subject: CHEBI:63616

subject_name: Pemetrexed

object_name: malignant pleural mesothelioma


subject: CHEBI:77590

subject_name: Armodafinil

object_name: narcolepsy


subject: CHEBI:9654

subject_name: Trazodone

object_name: Depressed mood


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: chronic granulomatous disease


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Compulsion


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ovarian carcinoma


subject: CHEBI:72312

subject_name: Pasireotide

object_name: acromegaly


subject: CHEBI:6888


subject: CHEBI:5441

subject_name: Glyburide

object_name: diabetes mellitus


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: metastatic prostate carcinoma


subject: CHEBI:9622

subject_name: Tolterodine

object_name: Urinary incontinence


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: coronary artery disorder


subject: CHEBI:82718

subject_name: Efinaconazole

object_name: tinea unguium


subject: UNII:P341G6W9NB

subject_name: Deutetrabenazine

object_name: Dyskinesia


subject: CHEBI:608828

subject_name: Enfuvirtide

object_name: HIV infection


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Heartburn


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Herpesviridae infectious disease


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: urinary tract infection


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UNII:Z5N076G8YQ

subject_name: Fidaxomicin

object_name: Clostridium difficile colitis


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: diffuse large B-cell lymphoma


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan

object_name: non-Hodgkin lymphoma


subject: CHEBI:8499

subject_name: Propranolol

object_name: hypertension


subject: CHEBI:72564

subject_name: Temozolomide

object_name: glioma


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Angina pectoris


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:231425

subject_name: tolvaptan

object_name: heart failure


subject: CHEBI:64356

subject_name: Pregabalin

object_name: epilepsy


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: bipolar disorder


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: primary hyperparathyroidism


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: inherited lipid metabolism disorder


subject: CHEBI:48390

object_name: hyperparathyroidism


subject: CHEBI:9654

subject_name: Trazodone

object_name: sleep disorder


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: psoriatic arthritis


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Zygomycosis


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: coronary atherosclerosis


subject: UNII:T58MSI464G

subject_name: Acarbose

object_name: diabetes mellitus


subject: CHEBI:47381

subject_name: Diclofenac

object_name: migraine


subject: UNII:LKC0U3A8NJ

object_name: heart disorder


subject: CHEBI:74947

subject_name: Thalidomide

object_name: myelofibrosis


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: sinusitis


subject: CHEBI:7936

subject_name: Paroxetine

object_name: major depressive disorder


subject: CHEBI:681569

subject_name: Clofarabine

object_name: acute lymphoblastic leukemia


subject: CHEBI:3207

subject_name: Budesonide

object_name: ulcerative colitis


subject: CHEBI:9086

subject_name: Selegiline

object_name: Depressed mood


subject: CHEBI:63607

subject_name: Linezolid

object_name: pneumonia


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: acute myocardial infarction


subject: CHEBI:8805

subject_name: Repaglinide

object_name: type 2 diabetes mellitus


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: metastatic prostate carcinoma


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: gastritis


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: colitis


subject: CHEBI:3139

subject_name: bleomycin

object_name: Hodgkin Disease


subject: UNII:DQ448MW7KS

subject_name: Palivizumab

object_name: congenital heart disease


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Fever


subject: CHEBI:32293

subject_name: Verteporfin

object_name: macular degeneration


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: cancer


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: herpes simplex


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: lung cancer


subject: CHEBI:7476

subject_name: Naproxen

object_name: osteoarthritis


subject: CHEBI:31941

subject_name: Oxaliplatin


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Chest pain


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: uveitis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: bronchogenic carcinoma


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: non-small cell lung carcinoma


subject: CHEBI:31638

subject_name: Fulvestrant

object_name: hormone receptor-positive breast cancer


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: bipolar I disorder


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: acute lymphoblastic leukemia


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Panic attack


subject: CHEBI:174358

subject_name: Eslicarbazepine

object_name: epilepsy


subject: CHEBI:50924

subject_name: Sorafenib

object_name: thyroid tumor


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: Crohn disease


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: hemophagocytic syndrome


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: dyspepsia


subject: CHEBI:215747

subject_name: Tapinarof

object_name: psoriasis


subject: CHEBI:63577

subject_name: Lamivudine

object_name: chronic hepatitis B virus infection


subject: CHEBI:72323

subject_name: Alogliptin

object_name: type 2 diabetes mellitus


subject: UNII:L0HR9A577V

subject_name: Elranatamab

object_name: plasma cell myeloma


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: atrial fibrillation


subject: UNII:5YL4IQ1078

subject_name: Osilodrostat

object_name: Cushing syndrome


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: transitional cell carcinoma


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: choroidal neovascularization


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: cluster headache syndrome


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: squamous cell carcinoma


subject: CHEBI:3242

subject_name: butorphanol

object_name: migraine


subject: UNII:NWQ5N31VKK

subject_name: Daptomycin

object_name: endocarditis


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: exanthem


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: diffuse large B-cell lymphoma


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:135515

subject_name: Bendamustine

object_name: mantle cell lymphoma


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: food allergy


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: Urinary incontinence